EE122 CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling
Abstract
Authors
Abril Seyahian Mirre Scholte Chantal Gravesteijn Petronella Beatrix Ottevanger Petra L.M. Zusterzeel Ruud L.M. Bekkers Harry Dolstra Janneke Grutters